A novel approach to generate a recombinant toxoid vaccine against Clostridium difficile.
about
Reactive Oxygen Species as Additional Determinants for Cytotoxicity of Clostridium difficile Toxins A and BAdult vaccinationThe potential for emerging therapeutic options for Clostridium difficile infectionVaccines against human diarrheal pathogens: current status and perspectivesRecombinant Clostridium difficile toxin fragments as carrier protein for PSII surface polysaccharide preserve their neutralizing activityToxic shock syndrome toxin-1-mediated toxicity inhibited by neutralizing antibodies late in the course of continual in vivo and in vitro exposure.The roles of host and pathogen factors and the innate immune response in the pathogenesis of Clostridium difficile infection.Critical roles of Clostridium difficile toxin B enzymatic activities in pathogenesis.Masking autoprocessing of Clostridium difficile toxin A by the C-terminus combined repetitive oligo peptides.Recurrent Clostridium difficile infection: From colonization to cure.Breakthroughs in the treatment and prevention of Clostridium difficile infection.A chimeric protein comprising the glucosyltransferase and cysteine proteinase domains of toxin B and the receptor binding domain of toxin A induces protective immunity against Clostridium difficile infection in mice and hamsters.Development of a Novel Vaccine Containing Binary Toxin for the Prevention of Clostridium difficile Disease with Enhanced Efficacy against NAP1 StrainsSynthetic biology: biology by design.Clostridium difficile infection in the twenty-first century.Clostridium difficile infection: a worldwide disease.Vaccines against Clostridium difficile.Immune-based treatment and prevention of Clostridium difficile infection.Bezlotoxumab: anti-toxin B monoclonal antibody to prevent recurrence of Clostridium difficile infection.Development of Photodynamic Antimicrobial Chemotherapy (PACT) for Clostridium difficile.Vaccination against Clostridium difficile using toxin fragments: Observations and analysis in animal modelsDevelopment of a subunit vaccine for prevention of Clostridium difficile associated diseases: Biophysical characterization of toxoids A and B.Toxoid Vaccination against Bacterial Infection Using Cell Membrane-Coated Nanoparticles.Treatment of Clostridium difficile infection with a small molecule inhibitor of toxin UDP-glucose hydrolysis activity.
P2860
Q26770068-44A446C0-217B-4FB0-893A-713A9A81A7E4Q26824961-16A12F86-B864-4EF4-AE37-9CA7928B95A8Q28082059-3F568117-3F47-499C-9FB6-3971F08823B5Q33578045-E9EC8B0B-5DEC-4DA0-BE69-A2885E43674AQ33584866-68C347EA-2AA1-4E7B-867D-B02FF888B763Q33813616-4691115A-4170-488A-801C-F661DB805A4DQ34623572-B3C518BD-6049-4BF8-B155-AB63553BCF08Q34955649-27D5405A-3D24-487A-99AF-34437ACB7421Q35591558-B62EA135-59C8-4E84-8B0E-AA8739FF131EQ35822541-14F592C1-68A9-41A5-AFAB-8BE84F2BD3ADQ35918566-182F54D4-8CF9-4F77-9C7F-4E60E0A9970CQ36255845-1068DCEE-B6E5-4476-AFF9-B74C6B8FD401Q36261170-C3489B2E-DA68-4C5A-BCAB-B6B2636C60C3Q37111560-A1B01742-AB9C-43D2-99BA-79BD0093ACB1Q37289567-681EAC96-C6D4-4BC5-9E34-8BAF6F14B03BQ37563993-1A9CAC3A-3A8C-4D66-B99F-140E58DF5F8EQ38196682-526520C2-DC94-4166-9DBF-F1EA88241A1CQ38350907-1A46CBCD-6C47-4E67-99FF-A19743C9EC2BQ38668483-8013A2AB-A6E1-4AFF-AD4A-E8D66207B0E4Q38840387-5C0ACDE3-ABB5-4518-9FBE-5933F6442CC6Q40899692-6D35D95D-3E64-460F-BC96-65E906E61D86Q41682391-35DD7E10-72A7-4848-9617-C723BBD59535Q48116102-616E9298-DC85-42A0-8618-242EDA0C28F5Q51730586-AB51B779-D616-4A86-B09D-0E5350782B1D
P2860
A novel approach to generate a recombinant toxoid vaccine against Clostridium difficile.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
A novel approach to generate a recombinant toxoid vaccine against Clostridium difficile.
@en
A novel approach to generate a recombinant toxoid vaccine against Clostridium difficile.
@nl
type
label
A novel approach to generate a recombinant toxoid vaccine against Clostridium difficile.
@en
A novel approach to generate a recombinant toxoid vaccine against Clostridium difficile.
@nl
prefLabel
A novel approach to generate a recombinant toxoid vaccine against Clostridium difficile.
@en
A novel approach to generate a recombinant toxoid vaccine against Clostridium difficile.
@nl
P2093
P2860
P356
P1433
P1476
A novel approach to generate a recombinant toxoid vaccine against Clostridium difficile
@en
P2093
Annaliesa S Anderson
Anne Deatly
Cheryl Kotash
Elena Severina
Erik Johnson
Irina Yurgelonis
Kathrin U Jansen
Mini Sidhu
Narender Kalyan
Phillip Kwok Lee
P2860
P304
P356
10.1099/MIC.0.066712-0
P577
2013-04-29T00:00:00Z